HK1009813A1 - Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics - Google Patents

Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics

Info

Publication number
HK1009813A1
HK1009813A1 HK98110901A HK98110901A HK1009813A1 HK 1009813 A1 HK1009813 A1 HK 1009813A1 HK 98110901 A HK98110901 A HK 98110901A HK 98110901 A HK98110901 A HK 98110901A HK 1009813 A1 HK1009813 A1 HK 1009813A1
Authority
HK
Hong Kong
Prior art keywords
isoxazole
diagnostics
pharmaceuticals
crotonamide
derivatives
Prior art date
Application number
HK98110901A
Other languages
English (en)
Inventor
Stefan Muellner
Bernd Kirschbaum
Wilfried Schwab
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HK1009813A1 publication Critical patent/HK1009813A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK98110901A 1997-01-28 1998-09-24 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics HK1009813A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702988A DE19702988A1 (de) 1997-01-28 1997-01-28 Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika

Publications (1)

Publication Number Publication Date
HK1009813A1 true HK1009813A1 (en) 1999-06-11

Family

ID=7818547

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110901A HK1009813A1 (en) 1997-01-28 1998-09-24 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics

Country Status (20)

Country Link
US (3) US5977151A (es)
EP (1) EP0859000B1 (es)
JP (1) JP4163776B2 (es)
KR (1) KR100572808B1 (es)
CN (1) CN1120160C (es)
AR (1) AR010399A1 (es)
AT (1) ATE231495T1 (es)
AU (1) AU729750B2 (es)
BR (1) BR9800501B1 (es)
CA (1) CA2228060C (es)
CZ (1) CZ296122B6 (es)
DE (2) DE19702988A1 (es)
DK (1) DK0859000T3 (es)
ES (1) ES2189010T3 (es)
HK (1) HK1009813A1 (es)
HU (1) HUP9800147A3 (es)
PL (1) PL194932B1 (es)
PT (1) PT859000E (es)
RU (1) RU2192421C2 (es)
TR (1) TR199800117A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355678B1 (en) * 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
WO2003042193A1 (en) * 2001-11-09 2003-05-22 Geneva Pharmaceuticals, Inc. Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide
US6727272B1 (en) 2002-07-15 2004-04-27 Unitech Pharmaceuticals, Inc. Leflunomide analogs for treating rheumatoid arthritis
US7632916B2 (en) * 2002-08-02 2009-12-15 3M Innovative Properties Company Process to modify polymeric materials and resulting compositions
US7157283B2 (en) * 2002-08-02 2007-01-02 3M Innovative Properties Company Continuous process for the production of combinatorial libraries of modified materials
US7125902B2 (en) * 2004-05-28 2006-10-24 Unitech Pharmaceuticals, Inc. Methods, compounds, and diagnostics for cancer treatment
WO2006074351A2 (en) * 2005-01-05 2006-07-13 Agencourt Personal Genomics Reversible nucleotide terminators and uses thereof
WO2008019139A2 (en) 2006-08-04 2008-02-14 Beth Israel Deaconess Medical Center Inhibitors of pyruvate kinase and methods of treating disease
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
US20100213060A1 (en) * 2009-02-23 2010-08-26 Bio-Rad Laboratories, Inc. Aqueous transfer buffer
AU2010234526B2 (en) 2009-04-06 2016-07-21 Agios Pharmaceuticals, Inc. Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
DK2427441T3 (en) 2009-05-04 2017-03-20 Agios Pharmaceuticals Inc PKM2 Activators for use in the treatment of cancer
NZ597379A (en) 2009-06-29 2014-04-30 Agios Pharmaceuticals Inc Therapeutic compounds and compositions
DK2448581T3 (en) 2009-06-29 2017-03-13 Agios Pharmaceuticals Inc Therapeutic compositions and methods for their applications
WO2012083246A1 (en) 2010-12-17 2012-06-21 Agios Pharmaceuticals, Inc. Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
CA2822432C (en) 2010-12-21 2019-09-24 Agios Pharmaceuticals, Inc. Bicyclic pkm2 activators
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
CN108451955B (zh) 2011-05-03 2022-02-01 安吉奥斯医药品有限公司 用于治疗的丙酮酸激酶活化剂
PL3307271T3 (pl) 2015-06-11 2024-02-05 Agios Pharmaceuticals, Inc. Sposoby stosowania aktywatorów kinazy pirogronianowej
EP3943543A4 (en) * 2019-03-19 2022-12-14 Mitsui Chemicals, Inc. PROPYLENE RESIN COMPOSITION, MOLDING AND PROPYLENE POLYMER
WO2023244542A1 (en) * 2022-06-13 2023-12-21 Yeefan Med Inc Methods for detecting b-isox precipitates or captured proteins as biofluid biomarkers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DE3935016A1 (de) * 1989-10-20 1991-04-25 Behringwerke Ag Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten
AU649421B2 (en) * 1990-05-18 1994-05-26 Sanofi-Aventis Deutschland Gmbh Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
US5744664A (en) * 1990-07-05 1998-04-28 Hoechst Aktiengesellschaft Cycloolefin copolymers (COCS) as substrate material for liquid-crystal displays
ATE128353T1 (de) * 1991-10-23 1995-10-15 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonsäureamidderiva e und deren verwendung als arzneimittel mit immunmodulatorischer eigenschaft.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
ATE154526T1 (de) * 1992-04-16 1997-07-15 Merck Patent Gmbh Aktivierte trägermaterialien, ihre herstellung und verwendung
ES2124801T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa.
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
US6024957A (en) * 1993-06-02 2000-02-15 Research Corporation Technologies, Inc. Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same

Also Published As

Publication number Publication date
PL194932B1 (pl) 2007-07-31
PL324549A1 (en) 1998-08-03
AR010399A1 (es) 2000-06-07
EP0859000A1 (de) 1998-08-19
BR9800501B1 (pt) 2010-05-18
EP0859000B1 (de) 2003-01-22
TR199800117A3 (tr) 1998-08-21
HUP9800147A3 (en) 1999-01-28
CZ24998A3 (cs) 1998-08-12
US6265588B1 (en) 2001-07-24
RU2192421C2 (ru) 2002-11-10
CA2228060C (en) 2008-01-08
BR9800501A (pt) 1999-12-07
DK0859000T3 (da) 2003-05-12
CN1189491A (zh) 1998-08-05
CN1120160C (zh) 2003-09-03
DE19702988A1 (de) 1998-07-30
KR19980070841A (ko) 1998-10-26
PT859000E (pt) 2003-06-30
AU729750B2 (en) 2001-02-08
JPH10231279A (ja) 1998-09-02
DE59806965D1 (de) 2003-02-27
KR100572808B1 (ko) 2006-10-13
TR199800117A2 (xx) 1998-08-21
HU9800147D0 (en) 1998-03-30
ES2189010T3 (es) 2003-07-01
CA2228060A1 (en) 1998-07-28
JP4163776B2 (ja) 2008-10-08
MX9800757A (es) 1998-10-31
US5977151A (en) 1999-11-02
ATE231495T1 (de) 2003-02-15
HUP9800147A1 (hu) 1998-07-28
AU5274898A (en) 1998-07-30
CZ296122B6 (cs) 2006-01-11
US6121479A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
HK1009813A1 (en) Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
KR19987002466A (en) Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
ZA989505B (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
HUP0004434A3 (en) Adamantane derivatives and pharmaceuticals containing them
PL314561A1 (en) Substituted n-(indolo-2-carbonyl) - glycinamides and their derivatives as antidiabetic agents
PL314603A1 (en) Substituted n-(indolo-2-carbonyl)-beta-alaninamides and their derivatives as antidiabetic agents
AU3577995A (en) Urea derivatives and their use as acat-inhibitors
IL115563A0 (en) Benzoxazole derivatives and pharmaceutical compositions containing the same
SG65705A1 (en) 3-Hydroxypiridine-2-carboxamidoesters their perparation and their use as pharmaceuticals
PH31455A (en) Acyl derivatives of azolone.
ZA974171B (en) Novel isoxazole derivatives and their use as herbicides
HUP0000719A3 (en) Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
HUP0100184A3 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds and pharmaceuticals comprising them
AP9500730A0 (en) Pharmaceuticals
ZA952410B (en) Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals
HUP9602977A2 (en) Arylpiperidine and arylpiperazine derivatives and drugs containing the same
PL325279A1 (en) Pyrazol-4-ylo-benzoyl derivatives and their application as herbicides
EP0810227A4 (en) ISOXAZOLE DERIVATIVES
GB9518553D0 (en) New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
SG52154A1 (en) Isothiazole derivatives and their uses
GB9426021D0 (en) Pharmaceuticals
IL123191A0 (en) Substituted phosphinic compounds and their use as pharmaceuticals
AU1894395A (en) Isoxazole derivatives and their use as herbicides
ZA952407B (en) Substituted heterocyclic carboxamides their preparation and their use as pharmaceuticals
ZA948580B (en) Substituted heterocyclic carboxamides their preparation and their use as pharmaceuticals

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120126